Advances in areas that include genomics, systems biology, protein structure determination
and artificial intelligence provide new opportunities for target-based antibacterial drug …

Antibiotic resistance is an enormous problem that is accountable for over a million deaths
annually, with numbers expected to significantly increase over the coming decades …

Antibiotic resistance (ABR) is a dire global health crisis, undermining the efficacy of
antibiotics and ranking among the top ten public health threats according to the World …

Disulfide bond (Dsb) proteins, especially DsbA, represent a promising but as‐yet‐unrealized
target in combating multidrug‐resistant (MDR) bacteria because their precise subcellular …

Natural products have a long history of success in treating bacterial infections, making them
a promising source for novel antibacterial medications. Curcumin, an essential component …

Antimicrobial resistance (AMR) is a global threat to human health since infections caused by
antimicrobial-resistant bacteria are life-threatening conditions with minimal treatment …

Finding new therapeutic strategies against Gram-negative pathogens such as Acinetobacter
baumannii is challenging. Starting from diphenyleneiodonium (dPI) salts, which are …

Despite the antibiotics currently on the market, we observe, these past years, an increase of
deaths due to bacterial infections. The main cause of this increase is the development of …